Ningbo City, China · Founded 2020 · Privately Held (backing)
Developer of a dry powder inhalation platform designed to advance formulation development, inhaler design, and inhaled drug manufacturing. Inhal Pharma is based in Ningbo City, China and was founded in 2020. It has raised $29.5 million.
Last price · $/share
—
Implied valuation
—
Total raised
$29.5M
Last round
—
Cap table — not yet on record
Inhal Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Inhal Pharma with a free account
·The complete investor list: 13 names
·Watch Inhal Pharma: the Monday email on marks, rounds and moves
